Longitudinal assessment of thyroid function in dogs with hypoadrenocorticism: Clinical outcomes and prevalence of autoantibodies
Journal of Veterinary Internal Medicine · 2025
DOI: 10.1111/jvim.17232 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2025. Written by Nadja S Sieber-Ruckstuhl and 9 co-authors. Institution: Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland. Major MEDLINE topics: Dog Diseases, Autoantibodies, Thyroxine, Thyrotropin. Cited 5 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Knowledge about primary hypoadrenocorticism coexisting with immune-mediated thyroiditis (Schmidt's syndrome) in dogs is limited.
Objective
To evaluate thyroid function in dogs with naturally occurring hypoadrenocorticism before and during treatment. Animals Sixty-six client-owned dogs.
Methods
Measurement of canine thyroid stimulating hormone (cTSH), total thyroxine (T4), free thyroxine, and autoantibodies against thyroglobulin, T4, and total triiodothyronine.
Results
Thirty-eight dogs were assessed before and 28 during treatment. Follow-up data were available for 24/38 and 17/28 dogs, with median follow-up duration of 3.8 years (range, <1.0-8.8 years) and 4 years (range, 1.1 weeks to 10.5 years), respectively. Canine thyroid stimulating hormone was above the reference range at the time of diagnosis of hypoadrenocorticism in 10 of 38 dogs but decreased into the reference range in 7 for which follow-up data was available. Hypothyroidism was confirmed in 5 dogs at a median age of 11 years (range, 7-15 years). In 4 dogs, the condition was diagnosed after a median treatment duration of 5.75 years (range, 2.6-10 years), while in 1 dog, the diagnosis was made concurrently. One dog had detectable thyroid autoantibodies. Conclusions and Clinical Relevance Hypothyroidism occurs as a rare concurrent condition in dogs with hypoadrenocorticism, potentially at any phase of treatment. Close monitoring of cTSH levels in these dogs could be beneficial, as early changes might indicate the onset of hypothyroidism. The low prevalence of detectable thyroid autoantibodies suggests that nonimmune mechanisms might contribute to thyroid dysfunction.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
- Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
ORCID profiles: Nadja S Sieber-Ruckstuhl, Federico Fracassi, Regina Hofmann-Lehmann, Felicitas S Boretti
Cite
APA
Sieber-Ruckstuhl, N. S., Riond, B., Fracassi, F., Kuemmerle-Fraune, C., Meunier, S., Hofmann-Lehmann, R., Reusch, C. E., Mueller, C., Hofer-Inteeworn, N., & Boretti, F. S. (2025). Longitudinal assessment of thyroid function in dogs with hypoadrenocorticism: Clinical outcomes and prevalence of autoantibodies. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17232
Vancouver
Sieber-Ruckstuhl NS, Riond B, Fracassi F, Kuemmerle-Fraune C, Meunier S, Hofmann-Lehmann R, et al. Longitudinal assessment of thyroid function in dogs with hypoadrenocorticism: Clinical outcomes and prevalence of autoantibodies. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.17232
BibTeX
@article{SieberRuckstuhl2025,
author = {Sieber-Ruckstuhl, Nadja S and Riond, Barbara and Fracassi, Federico and Kuemmerle-Fraune, Claudia and Meunier, Solène and Hofmann-Lehmann, Regina and Reusch, Claudia E and Mueller, Claudia and Hofer-Inteeworn, Natalie and Boretti, Felicitas S},
title = {Longitudinal assessment of thyroid function in dogs with hypoadrenocorticism: Clinical outcomes and prevalence of autoantibodies},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
doi = {10.1111/jvim.17232}
}
EUVIMED